Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussières J-F, Faye A, Brion F
Assistance publique-Hôpitaux de Paris, hôpital Robert-Debré, département de pharmacie et centre pluridisciplinaire de dosage des médicaments, Université Paris-V, 48 boulevard Sérurier, 75019 Paris, France.
Arch Pediatr. 2007 Apr;14(4):345-53. doi: 10.1016/j.arcped.2006.12.003. Epub 2007 Jan 26.
STATE OF THE PROBLEM AND OBJECTIVES: French pharmacists are quasi absent from hospital wards. Our objective was to describe the implantation of pharmaceutical care in a patient unit of a French paediatric hospital.
Following an internship in pharmaceutical care at the Sainte-Justine hospital (SJ) in Montreal, a French pharmacist returned to France to implement the pharmaceutical model in a paediatric unit at Robert Debré hospital (RD) in Paris. We first collected pharmaceutical interventions carried out during a 5-month period. In a second phase, we compared pharmaceutical interventions provided by the team composed of the same French pharmacist and a pharmacist from Québec in both settings during 14 days respectively.
In the first phase, 556 interventions were done (8.2+/-2,0 per day) with a significant increase observed during the first 2 months. In the second phase, 216 interventions were done at RD and 174 at SJ. The interventions were mainly related to drug information, modification of treatment and seamless care with the pharmacy of the hospital or a community pharmacy. The interventions targeted junior (30.5 to 55.4%), senior physicians (16.2 to 38.5%) and pharmacy (11.5 to 16.2%) in the different phases and sites. A high level of physician acceptance was observed, with respectively 86.0 and 93.1% at RD and SJ.
French pharmacists can apply the pharmaceutical care model following a specific training. Further studies are required to evaluate the feasibility and the impact of pharmaceutical care in France.
问题现状与目标:法国药剂师几乎不出现在医院病房。我们的目标是描述法国一家儿科医院的一个患者单元中药剂学照护的实施情况。
一名法国药剂师在蒙特利尔圣朱斯汀医院(SJ)完成药剂学照护实习后,回到法国,在巴黎罗伯特·德布雷医院(RD)的一个儿科单元实施药剂学模式。我们首先收集了5个月期间开展的药学干预措施。在第二阶段,我们比较了由同一名法国药剂师和一名来自魁北克的药剂师组成的团队在这两个地方分别在14天内提供的药学干预措施。
在第一阶段,共进行了556次干预(每天8.2±2.0次),在前两个月观察到显著增加。在第二阶段,RD进行了216次干预,SJ进行了174次干预。这些干预主要涉及药物信息、治疗调整以及与医院药房或社区药房的无缝衔接。在不同阶段和地点,干预对象主要是初级(30.5%至55.4%)、高级医师(16.2%至38.5%)和药房(11.5%至16.2%)。观察到医师接受度较高,在RD和SJ分别为86.0%和93.1%。
法国药剂师经过特定培训后可以应用药剂学照护模式。需要进一步研究来评估法国药剂学照护的可行性和影响。